50 completed, 5 terminated, 1 recruiting, 1 unknown. 25 Phase 3, 17 Phase 4, 7 Phase 2, 5 Phase 1, 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 25 | Completed 22, Terminated 2, Recruiting 1 |
| Phase 4 | 17 | Completed 12, Terminated 3, Unknown 1, Withdrawn 1 |
| Phase 2 | 7 | Completed 7 |
| Phase 1 | 5 | Completed 5 |
| Not applicable | 3 | Completed 3 |
Follow Risedronate: new trials by email Literature Review of Risedronate trials Research Report on Risedronate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric Surgery Risedronate, Placebo - Bone Loss | Phase 3 | Recruiting | Wake Forest University Health Sciences | 200 | 2023-03-28 | 2026-02-19 |
| Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients Risedronate, Vitamin D - Postmenopausal Osteoporosis, Hypovitaminosis D | Not applicable | Completed | Hospital Regional 1o de Octubre | 33 | 2021-07-01 | 2022-04-26 |
| Replication of the VERO Osteoporosis Trial in Healthcare Claims Data Teriparatide, Risedronate - Osteoporosis | Completed | Brigham and Women's Hospital | 12757 | 2020-10-29 | 2023-07-27 | |
| Prophylactic Risedronate for Patients With Peripheral Lung Tumors Treated With SBRT risedronate, Matching placebo - Lung Neoplasm | Phase 2 | Completed | Wake Forest University Health Sciences | 84 | 2019-07-12 | 2026-08-03 |
| Efficacy of Risedronate in Patients With Painful Periprosthetic Resorption of the Hip Prothesis risedronate, placebo - Prosthesis Loosening | Phase 3 | Terminated | University Hospital, Limoges | 3 | 2016-05-01 | 2018-10-17 |
| Heartland Osteoporosis Prevention Study Calcium Carbonate, Vitamin D3, Risedronate - Osteopenia | Phase 3 | Completed | University of Nebraska | 276 | 2015-02-01 | 2023-10-05 |
| Short-term Functional Recovery Between Early- and Late Bisphosphonate Treatment Following Hemiarthroplasty Risedronate - Osteoporotic Fractures, Femoral Neck Fracture | Phase 4 | Unknown | Mahidol University | 86 | 2013-06-01 | 2016-09-14 |
| VERtebral Fracture Treatment Comparisons in Osteoporotic Women Teriparatide, Risedronate, Placebo - Postmenopausal Osteoporosis | Phase 4 | Completed | Eli Lilly and Company | 1366 | 2012-10-01 | 2019-09-23 |
| IGF-1 and Bone Loss in Women With Anorexia Nervosa rhIGF-1, Risedronate, Placebo - Anorexia Nervosa, Osteopenia | Not applicable | Completed | Massachusetts General Hospital | 148 | 2011-10-01 | 2020-07-17 |
| Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With Osteoporosis Risedronate/Cholecalciferol combination, Risedronate - Osteoporosis | Phase 4 | Completed | Hanlim Pharm. Co., Ltd. | 1053 | 2011-07-04 | 2019-08-05 |
| Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352) Alendronate, Etidronate, Ibandronate - Esophageal Cancer, Squamous Cell Carcinoma | Completed | Organon and Co | 684815 | 2010-02-26 | 2022-02-03 | |
| Post-menopausal Women Osteoporosis(Phase III) risedronate combine, Risedronate, Placebo(for Risedronate) - Postmenopausal Women Osteoporosis | Phase 3 | Completed | Hanlim Pharm. Co., Ltd. | 150 | 2009-11-01 | 2013-03-07 |
| Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer Risedronate, Placebo - Breast Cancer, Menopause | Phase 3 | Completed | Hospices Civils de Lyon | 20 | 2009-11-01 | 2013-10-31 |
| Study to Evaluate the Safety and Efficacy of Denosumab and Actonel® in Post Menopausal Women Transitioned From Alendronate Therapy Actonel®, Denosumab - Osteoporosis | Phase 3 | Completed | Amgen | 870 | 2009-09-01 | 2020-07-28 |
| A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture Teriparatide, Risedronate, Placebo - Osteoporosis | Phase 4 | Completed | Eli Lilly and Company | 224 | 2009-04-01 | 2019-09-25 |
| Food Effects on the Relative Bioavailability of Different Dosages of Risedronate risedronate - Postmenopausal, Non-lactating | Phase 1 | Completed | Warner Chilcott | 94 | 2008-07-01 | 2011-10-12 |
| Bone Microarchitecture in Osteopenic Postmenopausal Women placebo, risedronate - Osteoporosis | Phase 4 | Terminated | Warner Chilcott | 13 | 2008-07-01 | 2013-04-22 |
| Effect of Actonel on Periodontal Health of Postmenopausal Women Risedronate - Periodontal Disease | Phase 4 | Withdrawn | University Hospitals Cleveland Medical Center | 2008-01-01 | 2022-07-19 | |
| Assess Bioequivalence of One 150 mg Risedronate Tablet Versus Two 75 mg Risedronate Tablets in Healthy Subjects Risedronate - Osteoporosis | Phase 1 | Completed | Warner Chilcott | 96 | 2008-01-01 | 2013-04-17 |
| Assess the Influence of a High-fat Meal on the Relative Bioavailability Of Two Formulations of Risedronate Risedronate - Bioavailability | Phase 1 | Completed | Warner Chilcott | 76 | 2007-11-01 | 2011-10-12 |
Showing 20 of 58. Sign in to see all of them.
Osteoporosis (28) · Bone Diseases, Metabolic (13) · Osteoporosis, Postmenopausal (11) · Prostatic Neoplasms (3) · Breast Neoplasms (2) · Osteitis Deformans (2) · Spinal Cord Injuries (2) · Spinal Fractures (2) · Adenocarcinoma (1) · Anorexia Nervosa (1) · Back Pain (1) · Bone Resorption (1) · Carcinoma, Squamous Cell (1) · Crohn Disease (1) · Cystic Fibrosis (1)
Warner Chilcott (14) · Sanofi (5) · Eli Lilly and Company (4) · Hanlim Pharm. Co., Ltd. (2) · Novartis Pharmaceuticals (2) · Toronto Rehabilitation Institute (2) · Wake Forest University Health Sciences (2) · Amgen (1) · Boston VA Research Institute, Inc. (1) · Brigham and Women's Hospital (1) · CMX Research (1) · Christopher Sweeney, MBBS (1) · Columbia University (1) · Danderyd Hospital (1) · Gilles Boire (1)
United States (31) · Canada (16) · France (12) · Spain (9) · Australia (8) · Belgium (8) · Germany (7) · Poland (7) · Argentina (6) · Italy (6) · Sweden (5) · United Kingdom (5) · Hungary (4) · Brazil (3) · Czechia (3)
B. Cathy Craven, MD, FRCPC (2) · Hyoung-Moo Park, MD (2) · Aasis Unnanuntana, MD (1) · Alec Walker, MD, DrPH (1) · Amy Sun, MD, PhD (1) · Ana Balske, MD, PhD (1) · Ana M Balske, MD (1) · Ana M Balske, MD, PhD (1) · Angela Rogers, Dr (1) · Anne Klibanski, MD (1) · Antonio A Lazzari, MD (1) · CC Mok, MD FRCP (1)
PMID 38979716, PMID 17244788, PMID 21947137, PMID 22750403, PMID 22797188, PMID 23099796, PMID 23149277, PMID 23322362, PMID 24126237, PMID 26572609, PMID 27576310, PMID 28283937, PMID 29129436, PMID 29329484, PMID 30659410, PMID 31776637, PMID 32157334, PMID 32474650, PMID 33270906, PMID 34519832, PMID 36625789
2005 (1), P30CA012197 (1), U01AR080969 (1)